2019 BioAsia Poster_EGFR screen kit

肺癌血液中cfDNA EGFR突變監控_DIgital PCR應用分享

弘晉生技集團參展2019年BioAsia生技展

Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab

Pathogenic Germline Variants in 10,389 Adult Cancers

Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer

Taiwan Biotech Exop 2018

<參展預告> 2018年台灣生技展 BioTaiwan Exhibition

Femtopath citation update: Journal of Thoracic Oncology, Volume 13, Issue 6, 2018.

Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer